NEW YORK (GenomeWeb News) - Steven Gutman, director of the Office of In Vitro Diagnostic Device Safety and Evaluation, will leave the US Food and Drug Administration by the end of the year for a post in academia, GenomeWeb Daily News sister publication Pharmacogenomics Reporter reported today.
“I made the very difficult decision that it was time for a change,” Gutman told PGx Reporter this week.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.